PRODIGE 86 (FFCD 2103 – GONO – ENGIC 02) – FOLFIRINOX SBA: Phase II randomized trial to evaluate mFOLFIRINOX and mFOLFOX for locally advanced or metastatic small bowel adenocarcinoma

ANNÉE

2024

AUTEURS

Aparicio T, Turpin A, Zaanan A, de la Fouchardière C, Le Malicot K, Lonardi S, Paul Modest D, Wilson R, Ballhausen A, Graham J, Guarssifi M, Svrcek M, Laurent Puig P, Manfredi S

CONGRÈS/REVUE

ESMO

ÉTUDE

Localisation

LIEN PUBLICATIONS ASSOCIÉES